Nuclear enzyme discovery unlocks new paths to combat breast cancer
One of the major challenges in the treatment of the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance.
Read original article on The Medical News →Related news
-
Two charged in scheme to sell counterfeit Ozempic—how you can spot fake meds
United Kingdom
-
Precisely timed signals recreate key antibody factory features in human blood cells
United Kingdom
-
Study shows how music may help tackle addiction
United Kingdom
-
HIV patients with cancer must travel farther than others to access clinical trials
United Kingdom
-
AI-guided light analysis could help assess skin cancer and reduce unnecessary biopsies
United Kingdom
-
Is your patient chatting with AI? new tool guides psychiatrists on assessing patients' AI use
United Kingdom
-
Feeling sick may reflect widespread changes in brain activity, mouse study suggests
United Kingdom
-
Biokineticists fight disease using exercise science: How to bring their skills to rural patients
United Kingdom